Search Results - Carole Sips
- Showing 1 - 3 results of 3
-
1
P41 Assessment of cognitive function in a randomized, placebo-controlled, interventional trial conducted in patients with moderate-to-severe systemic lupus erythematosus (SLE) by Tirtha Sengupta, Carole Sips, Alexandre Avrameas, Evan D Remington, Jelena Curcic, Kristin Hannesdottir, Valeria De Luca, Stephen J Oliver
Published in Lupus Science and Medicine (2024-03-01)Article -
2
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study by Renaud Felten, Nan Shen, Julia Weinmann-Menke, Ana Malvar, Peter Gergely, Tamas Shisha, Carole Sips, André Serra-Roma, Markus Weiss, Rambabu Danekula, Jan Rohr
Published in RMD Open (2025-08-01)Get full text
Article -
3
LO-021 Interim safety and efficacy of subcutaneous (s.c.) dose ianalumab (VAY736; anti-BAFF-R mAb) administered monthly over 28 weeks in patients with systemic lupus erythematosus... by Yuko Kaneko, Masato Okada, Stephanie Finzel, Nan Shen, Elena Vishneva, Lingyun Sun, Bernadette Rojkovich, Alberta Hoi, Shin-Seok Lee, Piotr Leszczyński, Lie Dai, Rafal Wojciechowski, Cheng-Chung Wei, Katarzyna Romanowska-Prochnicka, Hiroshi Kaneko, Stanislav Ignatenko, Alexander Gordienko, Josefina Hernandez, Nancy Levin, Pongthorn Narongroeknawin, Hanna Ciferska, Masanari Kodera, Joung Liang Lan, Tunde Tarr, Yi Hsing Chen, Ajchara Koolvisoot, Eugeny Zotkin, Berta Paula magallares, Tirtha Sengupta, Carole Sips, Stephan Oliver
Published in Lupus Science and Medicine (2023-07-01)Article